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Highlights 
x Undifferentiated/differentiated SH-SY5Y cells provide distinct model 
systems 
x Parkin specifically sensitises to mitochondrial uncoupling 
x Kinases differentially regulate c-Jun activity depending on stress levels 
x Parkin exists in a feedback loop with c-Jun and its upstream kinases 
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3DUNLQVRQ¶VGLVHDVH3'LVdefined by the progressive loss of dopaminergic 
neurons. Mitochondrial dysfunction and oxidative stress are associated with PD 
although it is not fully understood how neurons respond to these stresses. How 
adaptive and apoptotic neuronal stress response pathways are regulated and the 
thresholds at which they are activated remains ambiguous. Utilising SH-SY5Y 
neuroblastoma cells, we show that MAPK/AP-1 pathways are critical in regulating the 
response to mitochondrial uncoupling. Here we found the AP-1 transcription factor c-
Jun can act in either a pro- or anti-apoptotic manner, depending on the level of stress. 
JNK-mediated cell death in differentiated cells only occurred once a threshold of stress 
was surpassed. We also identified a novel feedback loop between Parkin activity and 
the c-Jun response, suggesting defective mitophagy may initiate MAPK/c-Jun-
mediated neuronal loss observed in PD. Our data supports the hypothesis that 
blocking cell death pathways upstream of c-Jun as a therapeutic target in PD may not 
be appropriate due to crossover of the pro- and anti-apoptotic responses. Boosting 
adaptive responses or targeting specific aspects of the neuronal death response may 
therefore represent more viable therapeutic strategies. 
 
Abbreviations: AP-1 (activating protein-1), ASK1 (apoptosis signal-regulating kinase 
1), BDNF (brain-derived neurotrophic factor), ERK (extracellular signal-regulated 
kinase), IEG (immediate early gene), JNK (c-Jun amino N-terminal kinase), MAPK 
(mitogen-associated protein kinase), MOM (mitochondrial outer membrane), PD 
3DUNLQVRQ¶V GLVHDVH 5$ UHWLQRLF DFLG 526 UHDFWLYH R[\JHQ VSHFLHV 61SF
(substantia nigra pars compacta), TRE (TPA responsive element), UPS (ubiquitin-
proteasome system). 
 
Keywords: Mitophagy, Oxidative Stress, MAPK, AP-1 transcription factors, 
3DUNLQVRQ¶V6+-SY5Y. 
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3DUNLQVRQ¶VGLVHDVH(PD) is a neurodegenerative disorder characterised by the 
loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Although 
oxidative stress and mitochondrial dysfunction are prominent characteristics of familial 
and sporadic PD, the precise pathways driving pathological changes are yet to be fully 
defined. 
 
A number of studies have implicated immediate early gene (IEG) signalling in 
PD (1-9). IEG proteins, such as Fos and Jun transcription factors, are regulators of the 
early stress response. Fos and Jun proteins dimerise to form activating protein-1 (AP-
1) transcription factor complexes, which regulate the expression of genes containing 
WKH73$UHVSRQVLYHHOHPHQW75(FRQVHQVXVVHTXHQFH¶-TGA(G/C)TCA-¶within 
their promoter (10, 11). Increased activity of the AP-1 transcription factor c-Jun, a 
downstream target of c-Jun amino N-terminal kinase (JNK), has been found in 
dopaminergic neurons of PD patients (1), although JNK inhibition in clinical trials has 
yet to yield positive results (12). AP-1 activity and stability can be rapidly modulated by 
phosphorylation in response to stimuli (13), with JNK, an AP-1 regulator, implicated in 
several neurodegenerative conditions (14).  
 
The MAPK, extracellular signal-regulated kinase (ERK) can regulate the 
activity of JNK and c-Jun (15, 16), has been implicated in the mitochondrial stress 
response (17, 18) and regulates the neuronal response to different forms of L-DOPA-
induced oxidative stress via c-Jun (9). With the complexity of crosstalk, coupled with 
signal-dependent thresholds, it seems probable that multiple pathways coordinate 
adaptive and apoptotic stress responses in neurons. Even specific stress response 
mechanisms can share common elements or be activated in parallel (19). Cells initiate 
protective or apoptotic responses depending on the level or duration of stress. The 
capacity of the initial response dictates the eventual outcome (20). In post-mitotic 
neurons, adaptive responses are critical since their failure will lead to progressive 
neurodegeneration.  
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Most intracellular reactive oxygen species (ROS) are produced by 
mitochondria (21). Excessive ROS associated with PD are produced by dysfunctional 
mitochondria, which undergo selective autophagy, a process called mitophagy (22). 
The PARK2 (PARKIN) and PARK6 genes (encoding Parkin and PTEN-induced 
putative kinase 1 (PINK1), respectively) are linked to familial PD (23), with PARKIN 
mutations the most common cause of autosomal-recessive PD (24, 25). Upon 
mitochondrial depolarisation, PINK1 accumulates on the mitochondrial outer 
membrane (MOM), recruiting and activating the E3 ubiquitin ligase Parkin (26-28) to 
promote mitophagy (29). Excessive ROS activates the apoptosis signalling kinase 1 
(ASK1)/JNK pathway (30-33). As Parkin activity can repress JNK/c-Jun activity (4, 34) 
and c-Jun represses PARKIN expression (7), a feedback loop may exist between 
multiple pathways to determine the response to these stresses. 
 
Here we define the role played by MAPK/AP-1 pathways in the response to 
mitochondrial uncoupling, utilising SH-SY5Y neuroblastoma cells (35, 36). Our data 
suggests a finely balanced system in which feedback loops between c-Jun, Parkin and 
MAPK activity exist, allowing neurons to rapidly respond to mitochondrial damage and 
commit to apoptosis if irreversibly damaged. Dysfunction within this multi-faceted 
process may drive some neurodegenerative pathologies. 
 
2. Materials and methods  
 
2.1. Cell culture 
Wild type (WT) and Parkin overexpressing SH-SY5Y neuroblastoma cell lines 
were obtained from Dr Phil Robinson (37), the latter created by stable transfection of 
a pcDNA3.1/Hygro(+) vector (Invitrogen, Paisley, UK) containing PARKIN cDNA into 
cells followed by hygromycin B selection (Invitrogen). Cells were used between 
passage 7-16 and grown in DMEM/F12 GlutaMAXTM media supplemented with 10% 
FCS, 100µg/ml penicillin, 100µg/ml streptomycin and minimum essential media non-
essential amino acids (Gibco, Paisley, UK) at 37°C and 5% CO2. For differentiation, 
cells were seeded in standard culture medium for 24 hours, then incubated in medium 
containing 10µM retinoic acid (RA) for 3 days. RA medium was removed, cells washed 
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with PBS then serum-free medium containing 50ng/ml brain derived neurotrophic 
factor (BDNF) added for 3 days. HEK293 cell lines (38) were cultured in DMEM with 
10% FCS, 100µg/ml penicillin and 100µg/ml streptomycin (Gibco). 
 
2.2. Antibodies 
Antibodies specific for c-Jun (5B1, ab119944), JunD (EPR6520, ab134067), 
JunB (EPR6518, ab128878), c-Fos (2G2, ab129361), FosB (83B1138, ab11959), Fra-
1 (EP4711, ab124722), Fra-2 (EPR4713(2), ab124830), anti-mitochondria [MTCO2] 
(ab3298) and Histone H3 (1791, ab1791) were obtained from Abcam (Cambridge, 
UK). Anti-Parkin (Prk8) (4211), -c-Fos (9F6, 2250) and -phosphorylated c-Jun (Ser63) 
II (9261) obtained from Cell Signalling Technology (Hertfordshire, UK). Anti-ȕ-actin 
(A5441) was obtained from Sigma. Horseradish-peroxidase anti-mouse (P0260) and 
anti-rabbit (P0448) secondary antibodies were supplied by Dako (Stockport, UK). 
Highly-cross adsorbed (H+L) Alexa Fluor 488 anti-mouse (A11029) and Alexa Fluor 
594 anti-rabbit (A11037) secondary antibodies from Molecular Probes, Invitrogen. 
 
2.3. Cell proliferation assay 
Cells were trypsinised, resuspended in medium then stained with trypan blue 
DQG FRXQWHG XVLQJ D &RXQWHVV ,QYLWURJHQ 2 x 105 cells/well were seeded and 
incubated at 37°C for 72 hours. Cells were split and resuspended, then counts 
SHUIRUPHGXVLQJD&RXQWHVV 
 
2.4. CCCP assays 
Cells were seeded 24 hours before CCCP (Sigma, UK) was added to medium 
with gentle mixing. Cells scraped into PBS at specific time points and centrifuged at 
200xg for 5 min. Pellets frozen at -80qC for protein extraction. Epoxomicin (Santa Cruz 
Biotechnology, CA, USA) was added 1 hour prior to CCCP addition and SP600125 
(JNK inhibitor; Santa Cruz Biotechnology) or FR180204 (ERK inhibitor; Sigma) added 
2 hours prior to CCCP. 
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2.5. Western blotting 
Cell pellets were resuspended in ice-cold radioimmunoprecipitation assay 
buffer (RIPA) buffer (1% Nonidet-P-40, 0.5% sodium deoxycholate and 0.1% SDS in 
PBS) containing 1X Halt Protease and Phosphatase Inhibitor Cocktail (Pierce, 
Northumberland, UK) and 5mM EDTA, then left on ice for 30 min. Samples were then 
FHQWULIXJHGDW[JIRUPLQDW&DQGȝORIVXSHUQDWDQWXVHGIRUa Bradford 
Assay (BioRad, Hertfordshire, UK) to determine protein concentrations. Remaining 
supernatant mixed with equal volume of 2X SDS loading buffer containing 0.2M DTT 
and frozen at -20°C for western blotting.  
 
Using a Mini-Protean II electrophoresis cell (Bio-Rad), protein extracts were 
subjected to Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) at 100V in running buffer (25mM Tris base, 250mM glycine, 0.1% SDS). Protein 
was transferred to Hybond-C extra nitrocellulose membrane (Amersham, 
Buckinghamshire, UK) at 100V for 90 min in transfer buffer (25mM Tris base, 192mM 
glycine, 20% methanol, 0.01% SDS). Membranes were blocked in 5% (w/v) milk in 
PBS for one hour at room temperature (RT) then incubated with primary antibodies 
prepared at 1:1000 dilutions (ȕ-actin at 1:2000) in block overnight at 4°C. Membranes 
were washed 6 times in PBS-T then incubated with a 1:2000 dilution of horseradish 
peroxidase-conjugated secondary antibody in block for 1 hour at RT. Membranes were 
washed 6 times in PBS-T then once in PBS. Target antigens detected using enhanced 
chemiluminescence Super Signal West Pico or Femto reagents (Pierce) on a 
ChemiDoc MP Imaging System with Image Lab 4.0.1 (Bio-Rad) for densitometry.  
 
2.6. Immunofluorescence and CellROX® assays 
Cells grown on methanol-sterilised glass coverslip were treated as required 
then medium removed and washed in PBS, then incubated at RT for 20 min in 4% 
paraformaldehyde (PFA), washed 3 times in PBS and permeabilised with PBS-0.1% 
Triton X-100 for 5 min. If required, CellROX® Reagent was added to medium at a final 
concentration of 5ȝ0PLQXWHVSULRUWRfixation. Cells were washed 3 times in PBS 
then blocked in 0.1% milk powder in PBS for 30 min. Primary antibodies were prepared 
at 1:1000 dilutions (MTCO2 at 1:500) in block and centrifuged. Coverslips were 
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incubated with primary antibody solutions for 1 hour at RT then washed 3 times in 
PBS. Secondary antibodies were prepared at 1:500 dilutions in block (DAPI 1:1000) 
and centrifuged prior to 1 hour incubation with coverslips, which were washed 3 times 
in PBS after 1 hour. Coverslips mounted using Mowiol. Immunostaining was observed 
using a Nikon Eclipse Ti upright microscope supported by NIS Elements software. 
 
2.7. High-throughput immunofluorescence 
Cells were grown and treated in 96-well ViewPlates (PerkinElmer, Berkshire, 
UK). Fixation, permeabilisation and staining scaled down from above method before 
PBS added to each well. Plates were processed using the Operetta high-content/high-
throughput (HC/HT) wide-field fluorescence imaging system with Harmony software 
(PerkinElmer) with 20X or 40X objectives (10 or 17 fields of view per well, respectively). 
Up to 3 fluorescent channels were imaged. Focal planes determined at the start of 
each experiment. Images were analysed using Columbus software (PerkinElmer) in a 
non-biased manner. Objects around border of fields of view were excluded. The DAPI 
channel was used to detect nuclei (>30µm2 with contrast of over 0.10). Cell counts 
performed by Columbus software counting nuclei. TOTO3 imaged using far-red 
illumination. Mitochondria detected using Alexa Fluor 488. 
 
2.8. siRNA knockdown 
siRNA SMARTpools obtained from Dharmacon specific to JUN (c-JUN) (M-
003268-03-0005), JUNB (M-003269-01-00), JUND (M-003900-05-0005), FOS (c-
FOS) (M-003265-01-0005), FOSB (M-010086-03-0005), FOSL1 (FRA-2) (M-004341-
04-0005), FOSL2 (FRA-2) (M-004110-00-0005) and PARK2 (PARKIN) (M-003603-00-
0005). siRNA specific to non-targeting 1 (NT1) and polo-like kinase 1 (PLK1) were 
used as negative and positive transfection controls, respectively. A BLAST search was 
performed (http://blast.ncbi.nlm.nih.gov/Blast.cgi) for individual siRNAs in 
SMARTpools to predict for off-target effects. Final siRNA concentration was 50nM and 
carried out in duplicate. RNAiMAX transfection reagent mix was made up in Opti-MEM 
VHUXP IUHHPHGLXPDFFRUGLQJ WRPDQXIDFWXUHU¶V LQVWUXFWLRQV&HOOVZHUH VHHGHG at 
4,000 cells/well using a Fluid-X Xrd-384 dispenser and incubated for 48 hours with 
siRNA at 37qC in 96 well plates. 
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2.9.  RNA extraction and RT-qPCR 
RNA isolation was peUIRUPHG E\ DFFRUGLQJ WR WKH 75,]RO PDQXIDFWXUHUV¶
protocol (Life Technologies), with 1µl of RNase-free glycogen per sample prior to 
LVRSURSDQRO DQG 785%2 '1DVH NLW $PELRQ 8. DFFRUGLQJ WR WKH PDQXIDFWXUHUV¶
protocol. To quantify RNA, a NanoDrop® ND-1000 Spectrophotometer (Thermo 
Scientific, Loughborough, UK) was used. A 500ng dilution of RNA was made up in 5µl 
of RNase-free water, then heated to 65°C for 5 minutes after addition of 1µl random 
hexamers, 1µl dNTP mix (10mM dA, dC, dG and dT) and 7µl RNase-free water. After 
2 minutes on ice, samples were centrifuged then 4µl of 5X 1st strand buffer, 1µl 0.1M 
DTT and 1µl of SuperScript III reverse transcriptase (200U/µl) were added and 
incubated for 5 minutes. Samples were heated to 50°C for 50 minutes, followed by 
70°C for 15 minutes before cooling on ice. 
 
Reactions were run in duplicate in a MicroAmp® Optical 96-well Reaction Plate 
(Applied Biosystems, Warrington, UK) with a 20µl final volume in each well (1µl of 20X 
Taqman® Gene Expression Assay, 10µl of 2X Taqman® Gene Expression Master 
Mix, 7µl of RNase-free water and 2µl of 1:10 diluted cDNA) using the Taqman 
recommended qPCR cycle (50°C 2 minutes, 95°C 10 minutes, then; 95°C 15 seconds 
and annealing/extension at 60°C for 1 minute for 40 cycles) on the ABI 7500 Real Time 
PCR System (Applied Biosystems) using 7500 SDS software. Primer efficiencies were 
assessed. To calculate the relative expression level of a gene of interest (GOI) the 
''Ct method (39) was used for primer/probe efficiencies of 100% (-/+10%). To 
calculate relative expression using primers of <90% efficiency, the standard curve 
method was employed (40) then incorporated as part of the Livak method. 
 
2.10.  Statistical Analysis 
Independent biological repeats GHQRWHG E\ µn¶ values, refer to complete 
independent repeats of experiments. Error bars represent standard error of the mean 
(SEM) or standard deviation (SD) for mean values replicates. Statistical analysis was 
performed using Prism GraphPad 6 software. Appropriate tests were performed for 
individual experiments with post-hoc analysis if required. 
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3. Results 
 
3.1. Parkin overexpression sensitises cells to mitochondrial uncoupling. 
SH-SY5Y cells were used as a neuronal-like model to study the AP-1 response 
to mitochondrial stress, using CCCP to induce mitochondrial uncoupling and 
PINK1/Parkin-mediated mitophagy (26-29). Overexpression of Parkin was maintained 
post-differentiation with RA/BDNF (Fig 1A). Several differentiation protocols were 
assessed with RA/BDNF inducing the greatest neurite outgrowth (S1 Fig), a 
characteristic of SNpc dopaminergic neurons (41, 42), so this was chosen for further 
study. In undifferentiated cells, Parkin overexpression did not alter rate of proliferation 
(S1 Fig), but did sensitise cells towards differentiation (Fig 1B). 
 
Parkin is generally considered cytoprotective. However, we previously 
demonstrated that accelerating mitophagy through Parkin overexpression reduced cell 
viability upon mitochondrial uncoupling in HEK293 cells (38). To investigate the effect 
of Parkin overexpression in the SH-SY5Y stress response, undifferentiated WT and 
Parkin overexpressing SH-SY5Y cells were treated with CCCP, H2O2 (cellular 
oxidative stress), rotenone (complex I inhibitor) or epoxomicin (proteasomal inhibition) 
for 24 hours and surviving cells counted. Parkin specifically sensitised cells to 
mitochondrial uncoupling, but not other forms of stress (Fig 1C). 
 
CellROX® Green Reagent was used to determine ROS levels over a 24 hour 
period post-&&&3 WUHDWPHQW7UHDWPHQWRIFHOOVZLWKȝ0&&&3 LQGXFHGR[LGDWLYH
stress, with ROS levels peaking at around 2 hours and resolving back to basal levels 
by 24 hours (Fig 1D). This was cytotoxic but did not result in the death of the entire cell 
population after 24h (Fig 1C), thus was chosen for further study. 
 
3.2. c-Jun can act anti- or pro-apoptotically, depending on the 
mitochondrial stress level. 
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The Nrf2-mediated antioxidant response is epigenetically repressed in some 
neurons (43). AP-1-mediation of stress responses may therefore play a more pivotal 
role in neurons than in other cell types. AP-1 proteins in undifferentiated and 
differentiated SH-SY5Y cells were observed by immunofluorescence (S2 and S3 Figs). 
To investigate a functional role for AP-1 transcription factors in the mitochondrial stress 
response, a targeted siRNA screen was carried out. Individual JUN and FOS family 
genes, along with PARKIN, were knocked down prior to 24 hour CCCP treatment, then 
cells fixed, stained for DAPI and counted (Figure 1E). NT-1, a scrambled siRNA 
control, was used as a siRNA control for comparison. PLK1 knockdown, a positive 
control for transfection efficacy, resulted in significant cell death. Interestingly, PARKIN 
knockdown did not significantly reduce cell survival after uncoupling compared to 
control. c-FOS siRNA led to significant death in control cells, accounting for lower cell 
numbers in the CCCP-treated group. 
 
c-Jun is generally considered to be pro-apoptotic under stress conditions in 
neurons (1, 7, 44-46). In contrast, c-JUN knockdown caused an increase in CCCP-
induced cell death (Figs 1F and G). However, c-JUN knockdown prior to 30PM CCCP 
conversely reduced cell death (Fig 1H), suggesting a dual role for c-Jun in this context.  
In cells overexpressing Parkin, knockdown of c-JUN did not alter cell survival (Fig 1I). 
 
To further characterise the c-Jun response, western blotting was carried out 
over a time course. During the first 6 hours in undifferentiated WT cells, no significant 
change in total c-Jun levels was observed (Fig 2A), but S63 phosphorylated c-Jun 
became significantly elevated (Fig 2B), the latter even more so in differentiated cells. 
Parkin overexpression appears to perturb the decline observed in WT cells after their 
initial increase. Differentiation resulted in an exaggerated c-Jun response, consistent 
with the hypothesis that it may be more functionally important in neuronal cells. S63 
phosphorylated c-Jun/c-Jun ratios also differed between cell lines (Fig 2C).  
 
Over a longer period of uncoupling c-Jun levels were elevated (Fig 3A). Due to 
the sensitivity of differentiated cells to CCCP, it was only possible to examine this up 
to 12 hours post-uncoupling. Phosphorylation of c-Jun was distinct in each of 3 cell 
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lines assessed (Fig 3B), as were the phosphorylated c-Jun/c-Jun ratios (Fig 3C). 
Parkin overexpression again prevented the decline observed in WT cells after their 
initial increase Doublets of phosphorylated c-Jun were observed at 2 and 12 hours 
post-CCCP in differentiated cells, suggesting additional residues were 
phosphorylated. We also observed modulation of other AP-1 proteins (S4 ± S6 Figs).  
 
To monitor changes at transcriptional level, qPCR analysis was employed to 
assess relative changes in mRNA levels of AP-1 genes. Expression of all 3 JUN genes 
underwent modulation in response to mitochondrial uncoupling (Figs 3D & S7). c-JUN 
expression was regulated in a biphasic manner, with the initial increase in expression 
detected at 1 hour post-CCCP followed by a drop in mRNA levels between 2 and 6 
hours, which was then proceeded by a progressive increase. Changes in PARKIN 
expression showed that the mitophagic response was regulated at the transcriptional 
level (Fig 3E). To assess the potential c-Jun-mediated apoptotic response relative 
mRNA levels of BIM were assessed, as BIM upregulation in response to oxidative 
stress in neurons by JNK/c-Jun (47) is critical for neuronal apoptosis (48). 
Mitochondrial uncoupling led to a rapid increase in BIM expression (Fig 3F), which 
remained elevated throughout. These data suggested a role for c-Jun in the neuronal 
response to mitochondrial stress and so we aimed to investigate this further. 
 
3.3. The c-Jun response is differentially regulated by JNK and ERK 
AP-1 transcription factors undergo substantial regulation via MAPK-mediated 
phosphorylation (11), with JNK considered the primary c-Jun regulator (49) We 
therefore investigated the MAPK-dependent modulation of c-Jun by treating cells with 
SP600125, a JNK inhibitor, or FR180204, an ERK inhibitor, prior to mitochondrial 
uncoupling. It has been recently shown in SH-SY5Y cells that uncoupling and 
mitochondrial ATP output is relative to CCCP concentration (50). We therefore decided 
to investigate how this would affect MAPK regulation of c-Jun.  
 
Under lower mitochondrial uncoupling (5PM CCCP), JNK and ERK both acted 
to regulate overall c-Jun levels (Fig 4A). Although JNK inhibition prevented 
phosphorylation of c-Jun S63, ERK inhibition resulted in greater phosphorylation (Fig 
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4B), suggesting ERK repressed JNK-mediated phosphorylation of c-Jun. Under higher 
levels of uncoupling (30PM CCCP), the increase in c-Jun levels was regulated by ERK 
and supressed by JNK (Fig 4C). The transient boost in c-Jun S63 phosphorylation 2 
hours after uncoupling was also mediated by ERK, which again may be antagonised 
by JNK (Fig 4D). JNK and ERK are therefore likely to both be important under these 
conditions. 
 
3.4. JNK regulates cell death under high levels of mitochondrial stress in 
differentiated SH-SY5Y cells.  
MAPK inhibition was then examined in differentiated SH-SY5Y cells. JNK 
inhibition did not have a significant effect on cell death induced by lower uncoupling 
conditions, but did have a significant effect under higher levels of uncoupling (Figs 5A 
and 5B), increasing survival by around 6-fold. The lower concentration of JNK inhibitor 
failed to increase cell survival, as did ERK inhibition. This is consistent with a model in 
which JNK-regulated apoptosis is only initiated once a critical threshold of 
mitochondrial damage is passed. Undifferentiated Parkin overexpressing cells were 
significantly more sensitive to CCCP than WT cells (Fig 1C). This also appeared to be 
the case in differentiated cells, even with JNK inhibition (Fig 5C). 
 
Complete Parkin-dependent mitophagy requires ubiquitin-proteasome system 
(UPS) activity, with proteasomal inhibition blocking Parkin activity (38, 51). Autophagic 
inhibition alone does not perturb UPS-dependent degradation of outer membrane 
mitochondrial proteins (52). To investigate if proteasomal dysfunction exacerbated cell 
death in response to mitochondrial stress and whether this was regulated by MAPK 
signalling, proteasomal inhibition was induced using epoxomicin. This induced cell 
death in differentiated WT and Parkin SH-SY5Y cells, which was not rescued by MAPK 
inhibition (Figs 5D and 5E). However, JNK inhibition did rescue UPS-deficient cells 
also undergoing mitochondrial uncoupling.  
 
Data from non-neuronal models has demonstrated that mitochondria undergo 
perinuclear clustering early in mitophagy (28, 53-55). However, in neurons most 
mitochondria reside within axons and may not undergo somal degradation, with axonal 
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lysosomes and autophagosomes observed (56-58). Inducing damage in axonal 
mitochondria leads to rapid local recruitment of Parkin and other mitophagic machinery 
and localised clustering within autophagosomes (59).  
 
We asked whether the inhibition of specific pathways impacted on 
mitochondrial clustering upon uncoupling. Differentiated WT SH-SY5Y cells underwent 
uncoupling following MAPK/proteasomal inhibition and mitochondrial clustering was 
analysed 3 hours after CCCP treatment (Figs 5F, 5G and S8) with TOTO-3 staining 
labelling the cytoplasm for high-throughput image analysis (60). Uncoupling induced a 
significant increase in the number of mitochondrial clusters (Fig 5G). UPS inhibition 
reduced mitochondrial clusters post-uncoupling. JNK inhibition reduced mitochondrial 
clustering in UPS-deficient cells only at the highest level of uncoupling, suggesting that 
this pathway may only be activated in response to higher levels of mitochondrial 
damage. Although proteasomal inhibition antagonised mitochondrial clustering, no 
significant effect was found from the inhibition of either JNK or ERK alone. Thus, MAPK 
activity does not appear to regulate mitochondrial clustering. 
 
3.5. c-Jun activity under mitochondrial stress may be regulated by Parkin-
mediated mitophagy to form a regulatory feedback loop 
Parkin overexpressing cells showed a greater increase in c-Jun protein levels 
24 hours after mitochondrial uncoupling than WT cells (Fig 3A). c-Jun has previously 
been shown to repress PARKIN expression (7). We therefore investigated the link 
between c-Jun and Parkin-dependent mitophagy. As UPS activation is critical for 
mitophagy, we tested the effect that proteasomal inhibition had on the c-Jun response 
to mitochondrial uncoupling. c-Jun protein levels in UPS-deficient cells (Fig 6A) did not 
show the marginal reduction observed in the normal CCCP response (Fig 2A). 
Proteasomal inhibition in the absence of uncoupling did not significantly alter c-Jun 
protein levels (Fig 6B), thus control levels (-/+ epoxomicin) were a comparable basal 
point. Over a longer period of uncoupling, c-Jun levels became increasingly elevated 
in UPS-deficient cells (Fig 6C).  
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To investigate whether a specific functional link between c-Jun and Parkin 
existed, we used previously characterised HEK293 cell lines that inducibly over-
express different Parkin mutants (38). Some of these lines expressed non-functional 
PD-associated PARKIN mutations (T240R, R275Y, R42C) or reduced E3 ligase 
mutants (R42P), allowing us to assess whether modulation of c-Jun levels was 
dependent on Parkin E3 ligase activity. Compared to untransfected cells, the induction 
of WT Parkin expression and subsequent mitochondrial uncoupling resulted in a 
significant increase in c-Jun protein levels (Figs 6D and 6E). Cells expressing R42P 
Parkin, a functional mutant demonstrating reduced mitophagic activity (53, 61-63) 
exhibited a similar c-Jun induction profile to cells expressing WT Parkin. Expressing 
mutant forms of Parkin generally resulted in a down regulation of the c-Jun response 
to mitochondrial uncoupling. Strikingly, inducing the expression of the T240R mutant 
construct increased the c-Jun response to CCCP-induced stress. Notably, although 
the R275Y, R42C and T240R mutants are all E3 ligase-deficient, only the latter 
induced an elevation in c-Jun levels relative to WT Parkin upon uncoupling. 
 
4. Discussion 
We aimed to investigate how neuronal decisions to initiate either adaptive or 
apoptotic responses are made in response to mitochondrial stress. In particular, how 
mitophagic and signalling pathways interlinked to regulate different arms of the stress 
response. The SH-SY5Y neuron-like cell line was used to demonstrate the 
involvement of the JNK/c-Jun pathway in dictating response to mitochondrial 
dysfunction in a neuronal context. CCCP uncoupled mitochondria and induced 
oxidative stress and has been shown to induce apoptosis in SH-SY5Y cells at a wide 
range of concentrations (64-66). Utilising both undifferentiated and differentiated cells 
allowed the identification and functional analysis of MAPK and AP-1 pathways in this 
response. It also highlighted differences between these cell models, illustrating the 
importance of choosing an appropriate experimental system in such work. 
Furthermore, our results, along with previously published works, would suggest that 
MAPK inhibition may not be an effective therapeutic strategy in vivo due to it leading 
to the downregulation protective pathways, as well as the intended apoptotic 
pathways. 
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4.1. The role of c-Jun is dictated by the level of stress 
While many AP-1 transcription factors underwent modulation upon 
mitochondrial coupling, siRNA knockdowns suggested c-Jun can act in an anti- or pro-
apoptotic manner and that this was dependent on the level of mitochondrial damage. 
This c-Jun response was differentially regulated by JNK and ERK and this regulation 
was, again, dependent on the level of stress. Parkin overexpression or differentiation 
towards a more neuronal-like phenotype induced significant alterations in the early c-
Jun response to mitochondrial uncoupling. Differentiation resulted in an exaggerated 
c-Jun response, suggesting it may be more critical in neuronal cells.   
 
Several studies have implicated c-Jun as a pro-apoptotic factor in neuronal and 
non-neuronal cells undergoing different forms of stress (44-46, 67-69). Initially our 
results suggested that c-Jun was anti-apoptotic upon mitochondrial uncoupling. 
Further investigation revealed that under higher levels of mitochondrial dysfunction, c-
Jun promoted apoptosis. MAPK/c-Jun activity has recently been shown to regulate 
both cell death and survival under different levels of PD-associated stress (9). These 
data suggest biphasic modulation of c-JUN expression may allow c-Jun signalling to 
underpin responses to both lower and higher levels of mitochondrial stress and 
mediate an apoptotic or cytoprotective response, as appropriate. The level of stress 
would dictate how c-Jun protein levels and activity were altered. Dysregulation of this 
biphasic reaction at normally non-cytotoxic levels of mitochondrial damage (e.g. due 
to UPS dysfunction) could lower the threshold of stress at which c-Jun promotes 
neuronal apoptosis. 
 
4.2. MAPKs play a critical role in the regulation of c-Jun and the cell death 
response 
Our data revealed both JNK and ERK can regulate c-Jun protein levels and 
phosphorylation in response to differing levels of mitochondrial stress. It is likely that 
overall regulation reflects crosstalk between MAPK pathways (16), allowing alternative 
c-Jun activities to be dictated. Here, JNK-dependent cell death was not initiated by 
proteasomal dysfunction, but if mitochondrial depolarisation occurred in parallel with 
UPS-deficiency, the JNK pathway became dominant in inducing cell death. The idea 
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of inhibiting MAPKs such as JNK or ERK has been extensively explored in PD models, 
however, these data would suggest that inhibition upstream of transcription factors 
such as c-Jun will in fact lead to the inhibition of numerous other pathways, some of 
which will not be driving PD pathology. 
 
JNK has been previously proposed as a therapeutic target in 
neurodegenerative studies as it is generally associated with neuronal death (49, 70). 
Despite JNK inhibition in animal and cell models yielding promising results, a trial in 
PD patients involving the kinase inhibitor CEP-1347 was not successful (12). As JNK 
signalling plays a role in synaptic plasticity (71) and neuronal development (43), as 
well as our data suggesting it plays a role in the initial adaptive response, inhibition of 
this whole class of kinases could perturb protective activities that are normally 
functional in PD neurons. Indeed, it is likely that these endogenous protective 
pathways are in fact slowing down the progression of neurodegeneration, and thus 
their perturbation may accelerate disease pathology. 
 
4.3. Parkin and MAPK/AP-1 signalling 
Parkin activity has been linked to JNK repression (4, 34, 72-74) and can act 
both pro- and anti-apoptotically, depending on the level of stress (65). Additionally, 
JNK stabilises PINK1 under stress (75). Parkin overexpression increases sensitivity to 
mitochondrial uncoupling in HEK293 cells (38) and SH-SY5Y cells. BIM, induced by c-
Jun to initiate neuronal apoptosis (45), may regulate crosstalk between autophagy and 
apoptosis (76, 77) by promoting Parkin recruitment to mitochondria normally perturbed 
by pro-survival Bcl-2 proteins (66). Indeed, BIM accumulates on the MOM under stress 
to initiate BAX-dependent cytochrome c release (78). Therefore, chronic activation of 
the JNK/c-Jun pathway may lead to increased BIM-mediated recruitment of Parkin to 
damaged mitochondria, promoting apoptosis once a threshold of damage is 
surpassed.  
 
Our data suggests Parkin mutations that perturb its mitochondrial translocation 
lead to exacerbation of c-Jun signaling upon uncoupling. This is summarised in Table 
1 (26, 27, 38, 53, 54, 61-63, 79-82). This perturbation may represent a potential 
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mechanism by which c-Jun-dependent neuronal apoptosis occurs in some PD 
neurons. As JNK translocation to damaged mitochondria (83) induces neuronal 
apoptosis (84, 85) and  amplifies mitochondrial ROS production (86), it may be critical 
step in setting the threshold at which irreversible mitochondrial damage has occurred. 
Parkin could therefore function to regulate mitochondrial JNK signaling to manage the 
threshold of tolerable damage. When damage levels saturate adaptive responses, 
excessive mitochondrial JNK would shift the equilibrium towards apoptosis. Therefore, 
specifically targeting the inhibition of mitochondrial JNK, instead of all cellular JNK, 
may represent a better therapeutic target in order to prevent any unwanted dampening 
of JNK-mediated cytoprotection. Indeed, this translocation may be isoform specific, or 
rely on distinct phosphorylation events, to potentially regulate apoptotic c-Jun 
signalling. ATF4 upregulates PARKIN expression (7, 8) and is a critical regulator of the 
mitochondrial stress response (87). As c-Jun represses ATF4-mediated PARKIN 
expression (7), regulatory feedback loops would be critical in determining the 
appropriate pathways to activate (Fig 7). Under excessive stress c-Jun would supress 
PARKIN, antagonising cytoprotective Parkin-mediated mitophagy to facilitate 
apoptosis of irreversibly damaged cells. The fact we only observed increased 
apoptosis in Parkin overexpressing cells treated with CCCP and not H2O2 or rotenone 
indicates that this apoptotic promotion by Parkin is not due to oxidative stress, agreeing 
with previous data (65). Therefore, cross-talk between JNK/c-Jun and Parkin pathways 
could be critical in determining when a switch between adaptive/apoptotic responses 
occurs. 
 
4.4. Conclusions 
Previous studies have shown Parkin to regulate MAPK signalling (4, 34). 
Conversely, PARKIN expression can be regulated by the JNK/c-Jun pathway (7). ERK 
has also been shown to localise to damaged mitochondria in order to coordinate 
mitophagy (17). Although our data further suggests a critical role for MAPK/AP-1 in 
regulating mitochondrial damage-induced cell death, it is clear from additional studies 
that these pathways also regulate protective stress responses. Therefore, simple 
kinase inhibition could in fact be detrimental in an in vivo setting whereby disease 
progression occurs over decades due to these protective pathways constantly 
activating homeostatic mechanisms.  
AC
CE
PT
ED
 M
AN
US
CR
IPT
 MAPK/c-Jun response to mitochondrial damage  
18 
 
 
Nigral dopaminergic neurons demonstrate characteristics such higher basal 
levels of oxidative stress and greater axonal mitochondrial density due to increased 
bioenergetic demands compared to other neurons (41). This combination of factors 
potentially explains their specific degeneration in PD (42). How neuronal fate decisions 
are made in relation to the type or level of stress remains relatively unexplored. 
Perturbation of adaptive responses (e.g. by PARKIN mutations or non-specific MAPK 
inhibition) would lower this damage threshold by which apoptosis is activated and in 
cells such as nigral dopaminergic neurons that are both susceptible to damage and 
non-renewable this could lead to neurodegeneration. 
 
Previous studies have found that AP-1 proteins FosB, 'FosB and JunD are 
involved in long-term neuronal stress adaptations (88-92). Here, we focus on early 
adaptive responses within a novel feedback loop whereby Parkin activity modulates 
the c-Jun levels in response to mitochondrial stress, potentially relying on the 
mitochondrial recruitment of Parkin. As ROS is critical in regulating neuronal function 
(43, 71), it is important that stress response feedback loops in neurons function 
correctly to properly differentiate between survivable and cytotoxic levels of stress. 
Future work will therefore be crucial to dissect different neuronal pathways and identify 
specific proteins or events, such as the mitochondrial localisation of specific JNK 
isoforms and their regulation of c-Jun, that are unique to the neurodegenerative 
apoptotic responses. 
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Parkin mutant 
WT R275Y T240R S131A Y143F R42P R42C R275W T415N C289G G430D C352G K161N K211N 
Region of mutation n/a RING1 RING1 SH2-like domain 
SH2-like 
domain 
UBL 
domain 
UBL 
domain RING1 RING2 RING1 RING2 
IBR 
domain 
SH2-
like 
domain 
SH2-
like 
domain 
E3 ubiquitin ligase 
activity ض غ غ ض ض ض ? غ غ ? غ غ غ غ 
Mitophagy blocked 
by proteasomal 
inhibition 
ض n/a n/a ض غ ض n/a n/a n/a n/a n/a n/a n/a n/a 
Recruited to 
depolarised 
mitochondria 
ض ? غ ض ض ض ض ض ض غ غ ض ض ض غ 
Induces 
mitochondrial 
clustering 
ض غ غ ض ض ض ض Delayed ض غ غ غ غ ض غ 
Induces 
mitochondrial 
degradation 
ض غ غ ض ض ض غ غ غ غ غ غ غ غ 
Change in c-Jun 
levels 24h post-
CCCP (relative to 
WT) 
n/a Decrease Increase Decrease Decrease No 
change Decrease ? ? ? ? ? ? ? 
 
Table 1: Parkin mutations perturb mitophagy at different stages. Previous data 
demonstrates that dysfunction occurs at different stages of mitophagy depending on the Parkin 
mutant. To date, the steps at which this disruption occurs for each mutant shown here has not 
been fully elucidated. Our data suggests that Parkin translocation to mitochondria upon 
uncoupling may be critical in the regulation of c-Jun. Note: some studies demonstrate 
contradictory data and some boxes therefore contain both ticks and crosses. n/a = not 
DYDLODEOHµ"¶UHSUHVHQWVXQNQRZQ 
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Figure 1: Parkin and c-Jun play a role in CCCP-induced apoptosis. SH-SY5Y cells in 
undifferentiated form or differentiated form (differentiated E\ȝ0UHWLQRLFDFLG5$IRUGD\V
(10% serum) followed by 50ng/ml BDNF (no serum) for 3 days). (A) Western blot analysis 
revealed Parkin overexpression was maintained post-differentiation. (B) Parkin overexpression 
resulted in greater sensitivity to RA/BDNF differentiation. DAPI counts were performed using 
an Operetta system (n = 3) and analysed using an unpaired two-tailed t-test (****p < 0.001). (C) 
Parkin overexpression rendered undifferentiated cells more sensitive to mitochondrial 
XQFRXSOLQJ&HOOVSODWHGDWFHOOVZHOO IRUKRXUVZHUH WKHQH[SRVHG WRȝ0&&&3
ȝ0 +2O2 ȝ0 URWHQRQH RU Q0 HSR[Rmicin over a 24-hour period, then fixed and 
stained with DAPI and counts performed on an Operetta system (n = 4). Statistical significance 
ZDVDVFHUWDLQHGXVLQJDZD\$129$%RQIHUURQL¶V*p<0.05, **p<0.01). (D) Treatment of SH-
6<<FHOOVZLWKȝ0&&&3induced oxidative stress. Cells were stained with the mitochondrial 
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marker MTCO2 (red), CellROX® (green) and DAPI (blue). CellROX® Green staining showed 
(E) Knockdown by siRNA SMARTpools was performed 48 hours prior to CCCP challenge and 
cell counts (relative to DMSO-treated NT-1 knockdown cells) performed on an Operetta 
imaging system using DAPI-stained nuclei (n = 3). A siRNA screen of the AP-1 proteins and 
Parkin, using NT1 (non-targeting 1) and PLK1 (polo-like kinases) as negative and transfection 
controls respectively, showed c-Jun may play a role in the cell death response to mitochondrial 
uncoupling. (F) Knockdown of c-Jun was confirmed by western blot. Cell death for knockdowns 
was quantified using the Operetta system. (G) siRNA knockdown of c-Jun resulted in increased 
death induced by 5ȝM CCCP. (H) Under 30ȝM CCCP conditions, knockdown of c-Jun reduced 
cell death. (I) No significant alteration to the level of cell death was observed after c-Jun was 
knocked down prior to uncoupling in Parkin overexpressing cells. Statistical significance was 
assessed using an unpaired 2-tailed t-test (*p<0.05). Error bars represent SEM. 
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Figure 2: c-Jun is rapidly modulated in response to mitochondrial uncoupling. Western 
blot analysis was carried out on protein extracts obtained at specific time points after the 
treatment of undifferentiated/differentiated WT or undifferentiated Parkin overexpressing SH-
SY5Y cells with 5PM CCCP over a 6 hour period. Where required, cells were differentiated in 
ȝ05$ for 3 days (10% serum) followed by 50ng/ml BDNF (no serum) for 3 days prior to 
treatment with CCCP. Densitometry was calculated relative to the loading control (n = 3). (A) 
Statistically significant changes in c-Jun protein levels were observed in Parkin and 
differentiated SH-SY5Y lines. (B) Phosphorylated (S63) c-Jun levels show significant elevation 
after uncoupling. (C) Average values for total c-Jun and phosphorylated (S63) c-Jun levels were 
used to calculate the phospho/total c-Jun ratio over the first 6 hours of uncoupling. Statistical 
significance was determined using a ZD\$129$'XQQHWW¶Vp<0.05, **p<0.01, ***p<0.005). 
Quantified levels were compared to levels at time point 0.  Error bars represent SEM.  
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Figure 3: The c-Jun response to mitochondrial uncoupling is variably modulated over 
the 24 hour period of stress. Western blot analysis was carried out on protein extracts 
obtained at specific time points after the treatment of undifferentiated/differentiated WT or 
undifferentiated Parkin overexpressing SH-SY5Y cells with 5PM CCCP over a 24 hour period 
(n = 3). :KHUHUHTXLUHGFHOOVZHUHGLIIHUHQWLDWHGLQȝ05$ for 3 days (10% serum) followed 
by 50ng/ml BDNF (no serum) for 3 days prior to treatment with CCCP. Differentiated cells were 
highly sensitive to CCCP challenge and a sufficient quantity of extract was only obtained up to 
the 12 hour time point. Densitometry was calculated relative to the loading control. (A) 
Significant increases in c-Jun levels were observed in all 3 cell lines undergoing uncoupling. 
(B) Phosphorylated (S63) c-Jun levels showed more significant elevation in differentiated cells.. 
(C) Average values for total c-Jun and phosphorylated (S63) c-Jun levels were used to calculate 
the phospho/total c-Jun ratio over 24 hours of uncoupling. (D-E) cDNA obtained from RNA 
extracts over the 24h after 5PM CCCP challenge in undifferentiated WT SH-SY5Y cells was 
analysed for relative expression of the individual AP-1 genes by qPCR. Expression levels are 
relative to the 0h time point. (D) c-JUN expression was regulated in a biphasic manner upon 
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uncoupling. (E) PARKIN expression was upregulated in response to mitochondrial uncoupling. 
(F) BIM expression was upregulated within 1h of uncoupling, before dropping. qPCR Graphs 
show 2 independent biological repeats (1st ± blue, 2nd ± orange) with errors bars representing 
variation between technical replicates within a single experiment. Statistical significance was 
determined using a 2way ANOVA (DunneWW¶V p<0.05, **p<0.01, ***p<0.005, ****p<0.001). 
Quantified levels were compared to levels at time point 0.  Error bars represent SEM (westerns) 
or SD (qPCR). 
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Figure 4: JNK and ERK modulate c-Jun levels in response to different levels of 
mitochondrial stress. Western blot analysis was carried out on extracts obtained at different 
time points from undifferentiated WT SH-6<<FHOOVWKDWZHUHWUHDWHGZLWKȝ063RU
ȝ0 )5 K SULRU WR FKDOOHQJH ZLWK &&&3 $ ,QKLELWLRQ RI ERWK -1. DQG ERK 
suppressed the increase in c--XQ OHYHOV VHHQ LQ UHVSRQVH WR ȝ0 &&&3 % )ROORZLQJ
FKDOOHQJH ZLWK ȝ0 &&&3 -1. inihibition decreased c-Jun S63 phosphorylation, whereas 
ERK inhibition increased it. &,QUHVSRQVHWRȝ0&&&3(5.-induced c-Jun upregulation 
was perturbed by JNK activity. (D) ERK activity regulated transient c-Jun S63 phosphorylation 
in response to higher levels of uncoupling, while JNK contributed to the regulation of this 
phosphorylation (n = 2). Statistical significance was determined using a 2-way ANOVA 
7XNH\¶VUHODWLYHWRWKHLQKLELWRUYHKLFOHFRQWURO'062DWHDFKWLPHSRLQWp<0.05, **p<0.01, 
***p<0.005, ****p<0.001). Error bars represent SEM. 
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Figure 5: JNK promotes apoptosis in differentiated WT SH-SY5Y cells in response to 
high levels of mitochondrial stress. Cells were differentiated LQȝ05$ for 3 days (10% 
serum) followed by 50ng/ml BDNF (no serum) for 3 days in 96-well Operetta plates, then treated 
with SP600125 (JNK inhibitor), FR180204 (ERK inhibitor) and/or 100nM epoxomicin 
(proteasomal inhibitor) prior to CCCP exposure. Images were captured using an Operetta 
imaging system and analysed using Columbus software. Nuclei stained with DAPI (blue) and 
cytoplasm with TOTO-3 (cytoplasm). (A) Examples of images captured on the Operetta at 20X 
magnification. (B) A significant rescue in cell numbers by JNK inhibition was only seen in 
cultures challenged with high levels of CCCP (n = 4). (C) MAPK inhibition in differentiated 
Parkin overexpressing SH-SY5Y cells (n = 4). (D & E) JNK-mediated apoptosis did not occur 
in differentiated WT cells undergoing proteasomal inhibition, but was initiated upon the addition 
of mitochondrial uncoupling (n = 4). (F & G) Columbus software was used to analyse images 
captured using the Operetta. Mitochondrial clusters on the FITC channel (green) within the 
cytoplasm (TOTO3 ± red) were labelled and counted relative to nuclei on the DAPI channel. 
Mitochondrial clustering 3h post-CCCP challenge in differentiated WT SH-SY5Y cells was 
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perturbed by proteasomal inhibition but not MAPK inhibition (n = 3).  Statistical significance was 
determined using a 2-ZD\ $129$ 7XNH\¶V p<0.05, **p<0.01, ***p<0.005, ****p<0.001). 
Comparisons were made between inhibitor-treatment and inhibitor vehicle control of the same 
CCCP concentration, unless otherwise indicated by horizontal bars. Error bars represent SEM. 
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Figure 6: Parkin and c-Jun activity may be functionally linked. (A) Undifferentiated WT SH-
SY5Y cells were treated with 100nM epo[RPLFLQKSULRUWRFKDOOHQJHZLWKȝ0&&&3IRUXS
to 6h. Extracts were obtained at required time points for analysis by western blotting and c-Jun 
levels were calculated relative to E-actin. (n = 3). (B) Densitometric analysis of western blots 
showed c-Jun levels relative to E-actin were comparable with and without 1 hour 100nM 
epoxomicin treatment in the absence of CCCP (n = 3). (C) Over a 24h period of uncoupling 
following proteasomal inhibition, a massive increase in c-Jun levels was observed from 6h 
onwards compared to cells undergoing uncoupling without epoxomicin treatment (n = 3). (D) In 
a HEK293 model, expression of different Parkin constructs was induced by tetracycline for 24h. 
Cells were then treated with 5PM CCCP for 24h and protein extracts used to measure c-Jun 
levels by western blotting. Representative western blots for each Parkin mutant are shown. (F) 
Quantitative densitometric analysis of these blots was performed (n = 3). c-Jun levels were 
compared to those in cells not treated with CCCP or tetracycline for each Parkin construct 
unless otherwise shown. T240R appears to exacerbate the c-Jun response. Statistical 
significance was ascertained by 2-ZD\$129$%RQIHURQQL¶Vp<0.05, **p<0.01, ***p<0.005, 
****p<0.001). Error bars represent SEM. 
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Figure 7: Potential regulatory pathways in the neuronal response to mitochondrial 
damage in PD. (A) Increased ROS production occurs in damaged mitochondria. Acute bursts 
of mitochondrial ROS initiate redox-sensitive signalling as part of normal neuronal function, with 
Parkin suppressing mitochondrial MAPK activity. Under these physiological conditions where, 
unlike models using uncouplers to induce mitochondrial damage in order to exaggerate in vivo 
situations, Parkin is cytoprotective. (B) High levels of stress activates MAPK signalling, RO 
accumulation and Parkin-dependent degradation of MCL-1. This leads to JNK/c-Jun pathways 
inducing the expression of pro-apoptotic genes such as BIM. Models using Parkin 
overexpression models will, however, lower the threshold at which Parkin promotes apoptosis 
under uncoupling conditions. (C) Some Parkin mutations antagonise its stress-induced 
mitochondrial translocation and resulting suppression of MAPK signalling. Mitochondrial ROS 
production increased by mitochondrial JNK activity promotes neuronal death pathways, which 
may be exacerbated by the failure of mutant Parkin to initiate mitophagy. 
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